 |
|
Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma
Byung Ju Kang, Seung Won Ra, Kyusang Lee, Soyeoun Lim, So Hee Son, Jong-Joon Ahn, Byung Chul Kim
Tuberc Respir Dis. 2020;83(1):61-70. Published online 2019 Dec 24 DOI: https://doi.org/10.4046/trd.2019.0048
|
|
Citations to this article as recorded by
 Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
Eleonora Nicolò, Paolo Tarantino, Oriana D’Ecclesiis, Gabriele Antonarelli, Luca Boscolo Bielo, Antonio Marra, Sara Gandini, Edoardo Crimini, Federica Giugliano, Paola Zagami, Chiara Corti, Dario Trapani, Stefania Morganti, Carmen Criscitiello, Marzia Loc
The Oncologist.2024; 29(1): 75. CrossRef Circulating tumour cells for early detection of clinically relevant cancer
Rachel Lawrence, Melissa Watters, Caitlin R. Davies, Klaus Pantel, Yong-Jie Lu
Nature Reviews Clinical Oncology.2023; 20(7): 487. CrossRef Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters
Thi Ngoc Anh Nguyen, Po-Shuan Huang, Po-Yu Chu, Chia-Hsun Hsieh, Min-Hsien Wu
Cancers.2023; 15(22): 5372. CrossRef Tumour burden and efficacy of immune-checkpoint inhibitors
Filippo G. Dall’Olio, Aurélien Marabelle, Caroline Caramella, Camilo Garcia, Mihaela Aldea, Nathalie Chaput, Caroline Robert, Benjamin Besse
Nature Reviews Clinical Oncology.2022; 19(2): 75. CrossRef Recent advances in isolation and detection of circulating tumor cells with a microfluidic system
Rongkai CAO, Min ZHANG, Hao YU, Jianhua QIN
Chinese Journal of Chromatography.2022; 40(3): 213. CrossRef Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells
Siwen Wu, Shubi Zhao, Dawei Cui, Jue Xie, Liren Qian
Journal of Oncology.2022; 2022: 1. CrossRef Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
Karolina Buszka, Aliki Ntzifa, Barbara Owecka, Paula Kamińska, Agata Kolecka-Bednarczyk, Maciej Zabel, Michał Nowicki, Evi Lianidou, Joanna Budna-Tukan
Cells.2022; 11(18): 2871. CrossRef Therapeutic effects of in-vivo radiodynamic therapy (RDT) for lung cancer treatment: a combination of 15MV photons and 5-aminolevulinic acid (5-ALA)
Dae-Myoung Yang, Dusica Cvetkovic, Lili Chen, C-M Charlie Ma
Biomedical Physics & Engineering Express.2022; 8(6): 065031. CrossRef Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis
Durgesh Wankhede, Sandeep Grover, Paul Hofman
Cancers.2022; 14(24): 6112. CrossRef Biomarkers and diagnostic tools for lung cancer
Sang Hoon Lee, Eun Hye Lee, Eun Young Kim, Yong Jun Choi, Yoon Jin Cha, Yoon Soo Chang
Journal of the Korean Medical Association.2021; 64(1): 66. CrossRef Recent advances in diagnostic technologies in lung cancer
Hye Jung Park, Sang Hoon Lee, Yoon Soo Chang
The Korean Journal of Internal Medicine.2020; 35(2): 257. CrossRef Clinical Significance of Red Cell Distribution Width and Circulating Tumor Cells with an Epithelial–Mesenchymal Transition Phenotype in Lung Adenocarcinoma Huajian Peng, Xiang Tan, Yongyong Wang, Lei Dai, Guanbiao Liang, Jianji Guo, Mingwu Chen
Cancer Management and Research.2020; Volume 12: 5105. CrossRef From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Stephan Klöß, Susann Dehmel, Armin Braun, Michael J. Parnham, Ulrike Köhl, Susanne Schiffmann
Frontiers in Immunology.2020;[Epub] CrossRef Prediction of Potential Associations Between miRNAs and Diseases Based on Matrix Decomposition
Pengcheng Sun, Shuyan Yang, Ye Cao, Rongjie Cheng, Shiyu Han
Frontiers in Genetics.2020;[Epub] CrossRef
|